These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 10411559
1. Omeprazole has a dual mechanism of action: it inhibits both H(+)K(+)ATPase and gastric mucosa carbonic anhydrase enzyme in humans (in vitro and in vivo experiments). Puscas I, Coltau M, Baican M, Domuta G. J Pharmacol Exp Ther; 1999 Aug; 290(2):530-4. PubMed ID: 10411559 [Abstract] [Full Text] [Related]
5. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole. Kinoshita M, Saito N, Noto T, Tamaki H. J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931 [Abstract] [Full Text] [Related]
6. The inhibitory effect of diuretics on carbonic anhydrases. Puscas I, Coltau M, Baican M, Pasca R, Domuta G. Res Commun Mol Pathol Pharmacol; 1999 Apr; 105(3):213-36. PubMed ID: 10954127 [Abstract] [Full Text] [Related]
8. Prostaglandins with vasodilating effects inhibit carbonic anhydrase while vasoconstrictive prostaglandins and leukotriens B4 and C4 increase CA activity. Puscas I, Coltau M. Int J Clin Pharmacol Ther; 1995 Mar; 33(3):176-81. PubMed ID: 7599917 [Abstract] [Full Text] [Related]
19. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease. Mori H, Tonai-Kachi H, Ochi Y, Taniguchi Y, Ohshiro H, Takahashi N, Aihara T, Hirao A, Kato T, Sakakibara M, Kurebayashi Y. J Pharmacol Exp Ther; 2009 Feb 20; 328(2):671-9. PubMed ID: 18981288 [Abstract] [Full Text] [Related]